Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

AGM Statement

23 May 2007 11:49

Vernalis PLC23 May 2007 23 May 2007 VERNALIS PLC RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 23 MAY 2007 Vernalis plc announces that all resolutions proposed to shareholders at itsAnnual General Meeting held today were duly passed. All resolutions were approved on a show of hands. The number of proxy votesreceived for each resolution is set out below. Resolution For (including Against* Withheld discretionary votes)*Ordinary Resolution1. To receive theaudited accounts and related reports of theDirectors and auditors 224,569,857 (99.99%) 10,707 (0.01%) 7,1572. To approve theremuneration report 217,328,467 (99.63%) 813,306 (0.37%) 6,445,9483. To re-elect as a Director Dr A Baxter 224,545,392 (99.99%) 33,176 (0.01%) 9,1534. To re-elect as a Director Ms C C Ferguson 224,544,267 (99.98%) 38,844 (0.02%) 4,6105. To re-elect asa Director Mr J AD Slater 224,553,615 (99.99%) 28,646 (0.01%) 5,4606. To elect as aDirector Mr I Clark 224,542,703 (99.98%) 35,049 (0.02%) 9,9697. To re-appointPricewaterhouseCoopers LLP as auditors and to authorise the Directors to determine their remuneration 223,611,362 (99.65%) 792,957 (0.35%) 183,4028. To authorise the Directors to allot relevantsecurities 224,537,200 (99.98%) 37,797 (0.02%) 12,724Special Resolution9. To authorise the Directors to allot equitysecurities for cash 224,527,782 (99.98%) 39,519 (0.02%) 20,420Ordinary Resolution10. To approve the Vernalis plc Bonus Long-TermIncentive Plan 199,330,753 (91.39%) 18,789,501 (8.61%) 6,467,467 *NB: Percentage of votes cast excludes withheld votes Enquiries: Vernalis plc +44 (0)118 977 3133Simon Sturge, Chief Executive OfficerTony Weir, Chief Financial Officer Brunswick Group +44 (0)20 7404 5959Jon ColesAlex Tweed This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Mar 20125:29 pmRNSHolding(s) in Company
5th Mar 20125:39 pmRNSHolding(s) in Company
2nd Mar 20129:22 amRNSVoting Rights and Capital
28th Feb 201212:28 pmRNSResult of General Meeting
28th Feb 20127:00 amRNSResult of Open Offer
10th Feb 20124:53 pmRNSPublication of Combined Circular and Prospectus
10th Feb 20127:00 amRNSLicence Agreemt &Firm Placing &Placing &Open Offer
10th Feb 20127:00 amRNSVernalis and Tris Pharma Announce Collaboration
17th Jan 20127:00 amRNSVernalis & Servier Sign 3rd Oncology Collaboration
4th Jan 20127:00 amRNSVernalis enters collaboration with Genentech
19th Dec 20117:00 amRNSSecond Research Milestone Achieved
12th Dec 20117:00 amRNSVernalis Earns Final Milestone Payment from Ipsen
16th Nov 20117:00 amRNSInterim Management Statement
7th Nov 201111:43 amRNSHolding(s) in Company
3rd Oct 20117:00 amRNSMilestone Achieved and Collaboration Extended
28th Sep 20117:00 amRNSPositive Results for V158866 in Phase I Study
21st Sep 20117:00 amRNSResearch Milestone Achieved
8th Sep 20114:40 pmRNSSecond Price Monitoring Extn
8th Sep 20114:35 pmRNSPrice Monitoring Extension
24th Aug 20117:00 amRNSVernalis Initiates Phase I Trial of V81444
17th Aug 20115:16 pmRNSReplacement - Director/PDMR Shareholding
17th Aug 20114:35 pmRNSDirector/PDMR Shareholding
12th Aug 201110:00 amRNSDirector/PDMR Shareholding
5th Aug 201111:59 amRNSHolding(s) in Company
3rd Aug 20117:00 amRNSInterim results for six months ended 30 June 2011
3rd Aug 20117:00 amRNSAppointment of Non-Executive Director
2nd Aug 201111:30 amRNSVernalis Appoints Corporate Broker
22nd Jul 20117:00 amRNSNotice of Results for Six Months Ended 30 June '11
20th Jul 20117:00 amRNSAUY922 Update
5th Jul 20114:40 pmRNSSecond Price Monitoring Extn
5th Jul 20114:35 pmRNSPrice Monitoring Extension
15th Jun 201111:30 amRNSResult of AGM
8th Jun 20114:20 pmRNSHolding(s) in Company
26th May 20114:41 pmRNSSecond Price Monitoring Extn
26th May 20114:35 pmRNSPrice Monitoring Extension
26th May 20114:17 pmRNSListing Application, Voting Rights, Share Capital
23rd May 20114:58 pmRNSHolding(s) in Company
19th May 20114:40 pmRNSSecond Price Monitoring Extn
19th May 20114:35 pmRNSPrice Monitoring Extension
13th May 20117:00 amRNSTosedostat data to be presented at ASCO
11th May 20117:00 amRNSInterim Management Statement
6th May 20117:01 amRNSDirector/PDMR Shareholding
6th May 20117:00 amRNSDirector/PDMR Shareholding
4th May 20117:01 amRNSAnnual Information Update
4th May 20117:00 amRNSNotice of AGM
20th Apr 201111:57 amRNSHolding(s) in Company
12th Apr 20114:40 pmRNSSecond Price Monitoring Extn
12th Apr 20114:35 pmRNSPrice Monitoring Extension
12th Apr 20117:00 amRNSResults for the year ended 31 December 2010
12th Apr 20117:00 amRNSVernalis Regains A2A Receptor Antagonist Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.